Ottinger, Elizabeth
- National Center for Advancing Translational Sciences (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #70
- Top 1% Funded
- Sustained Excellence
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2015 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$22.6M
Full award amounts, FY2023
Award Records
8
Records listing this PI
Award-Linked Rank
#70
By linked amount among FY2023 PIs
Earliest Year Loaded
2015
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Ottinger, Elizabeth as a PI. Multi-PI records show the full award amount for context.
- 1ZIATR000375-05ZIAContact PIHelping to End Addiction Long-term (HEAL): Development of Clinical Candidate Drugs for Pain, Addiction and Overdose$8.6Maward amount
- 1ZIATR000281-07ZIAContact PIGene Therapy Platform for Rare Diseases$6Maward amount
- 1ZIATR000425-04ZIAContact PIA Treatment for Patients with Jansens Metaphyseal Chondrodysplasia (JMC)$2.3Maward amount
- 1ZIATR000026-09ZIAContact PIEvaluation of ACT1 to Treat Diabetic Keratopathy$1.6Maward amount
- 1ZIATR000019-09ZIAContact PIStudies of Tumor-Penetrating Microparticles for Pancreatic Cancer$1.4Maward amount
- 1ZIATR000426-04ZIAContact PIDeveloping an Integrated Rare Disease Bioinformatics Resource to Determine Phenotype to Genotype Correlations$1.4Maward amount
- 1ZIATR000439-02ZIAContact PIAntisense Oligonucleotide (ASO) Development for Rare and Neglected Diseases$1.1Maward amount
- 1ZIATR000441-02ZIAContact PICOVID-19: Identification and Development of Clinical Candidates to Treat SARS-CoV-2$161.9Kaward amount
Award organization
Organizations that administered FY2023 awards listing Ottinger, Elizabeth as a PI.
FY2023 award administered by National Center for Advancing Translational Sciences ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2015First NIH AwardNational Center for Advancing Translational Sciences
- 2015$500K Cumulative Funding
- 2015$1M Cumulative Funding
- 2015$2M Cumulative Funding
- 2015$5M Cumulative Funding
- 2015Entered Top 50% NationallyRanked #432
- 2015Entered Top 25% NationallyRanked #432
- 2015Entered Top 10% NationallyRanked #432
- 2015Entered Top 5% NationallyRanked #432
- 2016$10M Cumulative Funding
- 2018$25M Cumulative Funding
- 2023$50M Cumulative Funding
- 2023Entered Top 1% NationallyRanked #70